Shares of Novacyt S.A. (LON:NCYT – Get Free Report) traded up 10% during trading on Wednesday . The company traded as high as GBX 62.93 ($0.84) and last traded at GBX 62.93 ($0.84). 392,544 shares traded hands during trading, a decline of 35% from the average session volume of 600,336 shares. The stock had previously closed at GBX 57.20 ($0.77).
Novacyt Price Performance
The company has a quick ratio of 4.46, a current ratio of 2.92 and a debt-to-equity ratio of 15.71. The stock has a market capitalization of £44.45 million, a P/E ratio of -148.87 and a beta of -1.86. The business’s 50 day simple moving average is GBX 69.21 and its two-hundred day simple moving average is GBX 60.06.
About Novacyt
Novacyt SA, together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments.
Featured Stories
- Five stocks we like better than Novacyt
- Insider Selling Explained: Can it Inform Your Investing Choices?
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- CD Calculator: Certificate of Deposit Calculator
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- How to Invest in Blue Chip Stocks
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Novacyt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novacyt and related companies with MarketBeat.com's FREE daily email newsletter.
